High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families

被引:0
|
作者
Toyomasa Katagiri
Fujio Kasumi
Masataka Yoshimoto
Tadashi Nomizu
Kazuaki Asaishi
Rikiya Abe
Atsuo Tsuchiya
Masahiko Sugano
Shin-ichiro Takai
Mitsusato Yoneda
Takashi Fukutomi
Kiyoshi Nanba
Masujiro Makita
Hiroshi Okazaki
Kouichi Hirata
Minoru Okazaki
Yoshikazu Furutsuma
Yasuo Morishita
Yuuichi Iino
Takayuki Karino
Hiroyoshi Ayabe
Shinsuke Hara
Tetsuro Kajiwara
Syunsuke Houga
Tadao Shimizu
Masakazu Toda
Youji Yamazaki
Takashi Uchida
Kazufumi Kunitomo
Hiroshi Sonoo
Jun-ichi Kurebayashi
Koujiro Shimotsuma
Yusuke Nakamura
Y. Miki
机构
[1] Department of Human Genome Analysis,
[2] the Cancer Chemotherapy Center,undefined
[3] Japanese Foundation for Cancer Research,undefined
[4] 1-37-1 Kami-ikebukuro,undefined
[5] Toshima-ku,undefined
[6] Tokyo 170,undefined
[7] Japan Tel. +81-3-5394-3926; Fax +81-3-5394-3926 e-mail: yosmiki@hgc.ims.u-tokyo.ac.jp,undefined
[8] Laboratory of Molecular Medicine,undefined
[9] Institute of Medical Science,undefined
[10] The University of Tokyo,undefined
[11] Tokyo,undefined
[12] Japan,undefined
[13] Department of Surgery,undefined
[14] Japanese Foundation for Cancer Research,undefined
[15] Tokyo,undefined
[16] Japan,undefined
[17] Department of Surgery,undefined
[18] Hoshi General Hospital,undefined
[19] Koriyama,undefined
[20] Japan,undefined
[21] Sapporo Kotoni Nyuusen Clinic,undefined
[22] Sapporo,undefined
[23] Japan,undefined
[24] Second Department of Surgery,undefined
[25] Fukushima Medical College,undefined
[26] Fukushima,undefined
[27] Japan,undefined
[28] Department of Surgical Oncology,undefined
[29] Osaka University School of Medicine,undefined
[30] Osaka,undefined
[31] Japan,undefined
[32] Department of Surgery,undefined
[33] National Cancer Center Hospital,undefined
[34] Tokyo,undefined
[35] Japan,undefined
[36] Department of Surgery,undefined
[37] Breastpia Namba Hospital,undefined
[38] Miyazaki,undefined
[39] Japan,undefined
[40] Shin-Sapporo Nyuusen-Clinic,undefined
[41] Sapporo,undefined
[42] Japan,undefined
[43] First Department of Surgery,undefined
[44] Sapporo Medical College,undefined
[45] Sapporo,undefined
[46] Japan,undefined
[47] Furutsuma Clinic,undefined
[48] Osaka,undefined
[49] Japan,undefined
[50] Second Department of Surgery,undefined
来源
Journal of Human Genetics | 1998年 / 43卷
关键词
Key wordsBRCA1; BRCA2; Breast cancer family; Germline mutation; Missense mutation;
D O I
暂无
中图分类号
学科分类号
摘要
Mutations in either of two recently identified genes, BRCA1 and BRCA2, are thought to be responsible for approximately two-thirds of all cases of autosomal-dominantly inherited breast cancer. To examine the nature and frequency of BRCA1 and BRCA2 mutations in Japanese families exhibiting a high incidence of breast cancer, we screened 78 unrelated families in this category for mutations of these two genes. Examining the entire coding sequences as well as exon–intron boundaries of both genes by polymerase chain reaction (PCR) single-strand conformation polymorphism (SSCP) and multiplex-SSCP analysis, we identified possible disease-causing alterations in BRCA1 among affected members of 15 families and in BRCA2 in another 14 families. In 15 of those 29 families, the affected individuals carried missense mutations, although most germline mutations reported worldwide have been deletions or nonsense mutations. Our results, indicating that missense mutations of BRCA1 and BRCA2 tend to predominate over frameshifts or nonsense mutations in Japanese breast cancer families, will contribute signifi-cantly to an understanding of mammary tumorigenesis in Japan, and will be of vital importance for future genetic testing.
引用
收藏
页码:42 / 48
页数:6
相关论文
共 50 条
  • [41] Recurrent germline mutations in BRCA1 and BRCA2 genes in high risk families in Israel
    Yael Laitman
    Monica Simeonov
    Liron Herskovitz
    Anya Kushnir
    Shani Shimon-Paluch
    Bella Kaufman
    Jamal Zidan
    Eitan Friedman
    Breast Cancer Research and Treatment, 2012, 133 : 1153 - 1157
  • [42] BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients
    H Yazici
    O Bitisik
    E Akisik
    N Cabioglu
    P Saip
    M Muslumanoglu
    G Glendon
    E Bengisu
    S Ozbilen
    M Dincer
    S Turkmen
    I L Andrulis
    N Dalay
    H Ozcelik
    British Journal of Cancer, 2000, 83 : 737 - 742
  • [43] Founder mutations in BRCA1 and BRCA2 genes
    Ferla, R.
    Calo, V.
    Cascio, S.
    Rinaldi, G.
    Badalamenti, G.
    Carreca, I.
    Surmacz, E.
    Coliucci, G.
    Bazan, V.
    Russo, A.
    ANNALS OF ONCOLOGY, 2007, 18 : 93 - 98
  • [44] Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer
    Ramus, SJ
    KoteJarai, Z
    Friedman, LS
    VanderLooij, M
    Gayther, SA
    Csokay, B
    Ponder, BA
    Olah, E
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 60 (05) : 1242 - 1246
  • [45] BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients
    Yazici, H
    Bitisik, O
    Akisik, E
    Cabioglu, N
    Saip, P
    Muslumanoglu, M
    Glendon, G
    Bengisu, E
    Ozbilen, S
    Dincer, M
    Turkmen, S
    Andrulis, IL
    Dalay, N
    Ozcelik, H
    BRITISH JOURNAL OF CANCER, 2000, 83 (06) : 737 - 742
  • [46] PROBABILITY MODEL FOR PREDICTING BRCA1 AND BRCA2 MUTATIONS IN SPANISH FAMILIES WITH BREAST CANCER
    Diez, O.
    Rue, M.
    Balmana, J.
    Gadea, N.
    Bosch, N.
    Grana, B.
    Gutierrez-Enriquez, S.
    Romero, A.
    Perez-Segura, P.
    Diaz-Rubio, E.
    Caldes, T.
    de la Hoya, M.
    Alonso, C.
    Ramon y Cajal, T.
    Baiget, M.
    Lasa, A.
    Blanco, A.
    Santamarina, M.
    Fachal, L.
    Vega, A.
    Infante, M.
    Duran, M.
    Velasco, E. A.
    Chirivella, I.
    Osorio, A.
    Benitez, J.
    Esteban-Cardenosa, E.
    Bolufer, P.
    Segura, A.
    Brunet, J.
    Sanchez-Heras, B.
    Andres, R.
    Torres, A.
    Martnez de Duenas, E.
    Garcia-Casado, Z.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S601 - S601
  • [47] BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families
    Cherbal, Farid
    Bakour, Rabah
    Adane, Saida
    Boualga, Kada
    Benais-Pont, Gaelle
    Maillet, Philippe
    DISEASE MARKERS, 2010, 28 (06) : 377 - 384
  • [48] Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2
    M J L Ligtenberg
    F B L Hogervorst
    H W Willems
    P J W Arts
    G Brink
    S Hageman
    E A J Bosgoed
    E Van der Looij
    M A Rookus
    P Devilee
    E M A W Vos
    G Wigbout
    P M Struycken
    F H Menko
    E J Th Rutgers
    E H Hoefsloot
    E C M Mariman
    H G Brunner
    L J Van’t Veer
    British Journal of Cancer, 1999, 79 : 1475 - 1478
  • [49] BRCA1 and BRCA2 mutations in Belgian families with a history of breast and/or ovarian
    Sibille-Hoang, C
    Froment, O
    de ter Beerst, AJ
    Lepiece, V
    Huberlant, G
    Blauwaert, G
    Vindevoghel, A
    Canon, JL
    Gillerot, Y
    EUROPEAN JOURNAL OF CANCER PREVENTION, 1998, 7 : S3 - S5
  • [50] Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2
    Ligtenberg, MJL
    Hogervorst, FBL
    Willems, HW
    Arts, PJW
    Brink, G
    Hageman, S
    Bosgoed, EAJ
    Van der Looij, E
    Rookus, MA
    Devilee, P
    Vos, EMAW
    Wigbout, G
    Struycken, PM
    Menko, FH
    Rutgers, EJT
    Hoefsloot, EH
    Mariman, ECM
    Brunner, HG
    Van't Veer, LJ
    BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) : 1475 - 1478